COVID Vaccines Development/Procurement/Distribution/Policy – Russia, China

Milestones :: Perspectives :: Research

 

COVID Vaccines Development/Procurement/Distribution/Policy – Russia, China

Russia: Sputnik V – “the first registered COVID-19 vaccine” [to 16 Jan 2021]
https://sputnikvaccine.com/newsroom/pressreleases/
Press Releases
Sputnik V vaccine approved in Paraguay
Press release, 15.01.2021
… The vaccine was registered under the emergency use authorization procedure without additional clinical trials in the country. Sputnik V had been registered under the same procedure earlier in Algeria, Argentina, Bolivia, Serbia, Palestine and Venezuela.
Supplies of the vaccine will be facilitated by RDIF’s international partners in India, China, South Korea and other countries…

RDIF and União Química to supply 10 million doses of Sputnik V vaccine to Brazil
Press release, 13.01.2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and one of the leading pharmaceutical companies of Brazil União Química have agreed to supply to the country 10 million doses of the world’s first registered vaccine against coronavirus Sputnik V in the first quarter of 2021 with deliveries beginning in January…
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and one of the leading pharmaceutical companies of Brazil União Química have agreed to supply to the country 10 million doses of the world’s first registered vaccine against coronavirus Sputnik V in the first quarter of 2021 with deliveries beginning in January…

Algeria has become the first country in Africa to register Sputnik V vaccine
Press release, 10.01.2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by the National Agency of Pharmaceutical Products of People’s Democratic Republic of Algeria.
The vaccine was registered under the emergency use authorization procedure. Sputnik V has been registered under the same procedure earlier in Argentina, Bolivia and Serbia.
Supplies of the vaccine to Algeria will be facilitated by international partners of RDIF in India, China, South Korea and other countries…

 

::::::

China: COVID-19 Vaccines – Announcement/Regulatory Actions/Deployment

National Health Commission of the People’s Republic of China [to 16 Jan 2021]
http://en.nhc.gov.cn/
News
China to expand COVID-19 vaccination to include people aged over 60
2021-01-14

COVID-19 vaccine safe, effective, official says
2021-01-11
More than 9 million doses of COVID-19 vaccines have been administered across China, and the safety and efficacy of the vaccines have been proved, a top health official said.
With production increasing, the number of vaccine doses will be extended to cover the whole Chinese population free of charge as a crucial weapon for epidemic prevention and control, Vice-Health Minister Zeng Yixin said over the weekend…

China’s COVID-19 vaccine found capable of neutralizing UK strain
2021-01-11
China’s COVID-19 vaccine is found capable of neutralizing the new strain of the novel coronavirus that was reported to be behind the rise in transmission of the disease in parts of the United Kingdom, senior health official said on Jan 9.
Zeng Yixin, vice-minister of the National Health Commission, said China’s scientific community is paying close attention to the new variant and its effect on current vaccines as reports indicated that the new strain had arrived in China via imported cases.
Scientists from the Institute of Laboratory Animal Sciences of the Chinese Academy of Medical Sciences and the Sun Yat-sen University in Guangdong province are already working on the issue, Zeng said during a news briefing held by the State Council Information Office.
After examining the new viral strain and strains that existed in China from January to June last year, researchers found that the animal and human antibodies induced by China’s COVID-19 vaccine can neutralize the new variant, Zeng said, adding they have submitted their findings to scientific journals and is awaiting publication…

National Health Commission of the People’s Republic of China [to 16 Jan 2021]
http://en.nhc.gov.cn/
WHO team working with Chinese vaccine producers ahead of potential emergency use: WHO director-general
2021-01-13
GENEVA — The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus has said that a WHO team in China is working with producers of the Sinovac and Sinopharm vaccines for potential emergency use listings.
“I’m pleased that a WHO team is in China currently working with producers of the Sinovac and Sinopharm vaccines to assess compliance with international quality manufacturing practices ahead of potential emergency use listing by WHO,” Tedros said at a recent media briefing.
He noted that WHO continues to ask vaccine manufacturers from around the world to move swiftly to provide necessary data that will allow the organization to consider them for emergency use listings.
“While we are hopeful about the safe and effective vaccines that are being rolled out, we want to see this sped up and vaccines allocated equitably in the coming weeks,” Tedros said.